{"transactions":[{"id":4613717,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-09T21:54:20.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":7155,"price":60.36,"value":431875.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":95316,"source":{"system":"sec-edgar","filing":"0001230724-26-000018","document":"wk-form4_1788990858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000018/wk-form4_1788990858.xml","form_type":"4"}},{"id":1433,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:55.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1432,"price":61.58,"value":88182.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":102471,"source":{"system":"sec-edgar","filing":"0001230724-26-000016","document":"wk-form4_1788393412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000016/wk-form4_1788393412.xml","form_type":"4"}},{"id":1432,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:55.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":60.74,"value":77322.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":103903,"source":{"system":"sec-edgar","filing":"0001230724-26-000016","document":"wk-form4_1788393412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000016/wk-form4_1788393412.xml","form_type":"4"}},{"id":695693,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option is fully vested and exercisable."}],"balance_after":216827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695692,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":3044,"price":54.178,"value":164917.832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.07 to $54.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":105176,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695691,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6956,"price":53.761,"value":373961.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":108220,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695690,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":115176,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":715207,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option is fully vested and exercisable."}],"balance_after":226827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715206,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":2087,"price":57.764,"value":120553.468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.61 to $58.32. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":104395,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715205,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":7913,"price":57.157,"value":452283.341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.595 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":106482,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715204,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":732072,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is fully vested and exercisable."}],"balance_after":236827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":732071,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":53,"value":530000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."}],"balance_after":104395,"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":732070,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":848660,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-03-11T21:24:25.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1021,"price":59.32,"value":60565.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."}],"balance_after":104395,"source":{"system":"sec-edgar","filing":"0001230724-26-000008","document":"wk-form4_1773264262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000008/wk-form4_1773264262.xml","form_type":"4"}},{"id":874077,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:08:11.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":74993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":74993,"derivative":{"exercise_price":60,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":74993},"source":{"system":"sec-edgar","filing":"0001230724-26-000006","document":"wk-form4_1772500088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000006/wk-form4_1772500088.xml","form_type":"4"}},{"id":874076,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:11.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1009,"price":61.98,"value":62537.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":105416,"source":{"system":"sec-edgar","filing":"0001230724-26-000006","document":"wk-form4_1772500088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000006/wk-form4_1772500088.xml","form_type":"4"}},{"id":874075,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:11.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":898,"price":61.98,"value":55658.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":106425,"source":{"system":"sec-edgar","filing":"0001230724-26-000006","document":"wk-form4_1772500088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000006/wk-form4_1772500088.xml","form_type":"4"}},{"id":874074,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:11.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":44864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The\nRSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through\neach such date."}],"balance_after":107323,"source":{"system":"sec-edgar","filing":"0001230724-26-000006","document":"wk-form4_1772500088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000006/wk-form4_1772500088.xml","form_type":"4"}},{"id":890395,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:27:35.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001230724-26-000004","document":"wk-form4_1771626452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000123072426000004/wk-form4_1771626452.xml","form_type":"4"}},{"id":937174,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-01-16T22:09:55.000Z","date":"2026-01-14","kind":"gift","planned":false,"acquired":true,"shares":61850,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the sole annuitant and trustee."}],"balance_after":61850,"source":{"system":"sec-edgar","filing":"0001230724-26-000002","document":"wk-form4_1768601392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000002/wk-form4_1768601392.xml","form_type":"4"}},{"id":937173,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-01-16T22:09:55.000Z","date":"2026-01-14","kind":"gift","planned":false,"acquired":false,"shares":61850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involves the Reporting Person's transfer of shares to ALG 2025 GRAT HOLDINGS LLC, of which Reporting Person is the sole member and manager."}],"balance_after":62459,"source":{"system":"sec-edgar","filing":"0001230724-26-000002","document":"wk-form4_1768601392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000002/wk-form4_1768601392.xml","form_type":"4"}},{"id":1043994,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-09-10T20:26:42.000Z","date":"2025-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2890,"price":32.41,"value":93664.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":124309,"source":{"system":"sec-edgar","filing":"0001230724-25-000008","document":"wk-form4_1757535999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072425000008/wk-form4_1757535999.xml","form_type":"4"}},{"id":1047895,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-09-04T20:10:42.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1429,"price":31.56,"value":45099.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":127199,"source":{"system":"sec-edgar","filing":"0001230724-25-000007","document":"wk-form4_1757016639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072425000007/wk-form4_1757016639.xml","form_type":"4"}},{"id":1047894,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-09-04T20:10:42.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2381,"price":31.56,"value":75144.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":128628,"source":{"system":"sec-edgar","filing":"0001230724-25-000007","document":"wk-form4_1757016639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072425000007/wk-form4_1757016639.xml","form_type":"4"}},{"id":1047893,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-09-04T20:10:42.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1270,"price":31.56,"value":40081.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025."}],"balance_after":131009,"source":{"system":"sec-edgar","filing":"0001230724-25-000007","document":"wk-form4_1757016639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072425000007/wk-form4_1757016639.xml","form_type":"4"}},{"id":1174673,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-09T12:05:12.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":false,"shares":4777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Option is fully vested and exercisable."}],"balance_after":121115,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":4777},"source":{"system":"sec-edgar","filing":"0001649094-25-000049","document":"wk-form4_1744200305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000049/wk-form4_1744200305.xml","form_type":"4"}},{"id":1174672,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-04-09T12:05:12.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":true,"shares":4777,"price":20.93,"value":99982.61,"ownership":{"direct":true},"balance_after":131950,"source":{"system":"sec-edgar","filing":"0001649094-25-000049","document":"wk-form4_1744200305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000049/wk-form4_1744200305.xml","form_type":"4"}},{"id":1235757,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:32:20.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":75991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":75991,"derivative":{"exercise_price":74.22,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":75991},"source":{"system":"sec-edgar","filing":"0001649094-25-000043","document":"wk-form4_1741055534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000043/wk-form4_1741055534.xml","form_type":"4"}},{"id":1235756,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-03-04T02:32:20.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3809,"price":72.1,"value":274628.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":127173,"source":{"system":"sec-edgar","filing":"0001649094-25-000043","document":"wk-form4_1741055534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000043/wk-form4_1741055534.xml","form_type":"4"}},{"id":1235755,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-03-04T02:32:20.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1270,"price":73.02,"value":92735.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":130982,"source":{"system":"sec-edgar","filing":"0001649094-25-000043","document":"wk-form4_1741055534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000043/wk-form4_1741055534.xml","form_type":"4"}},{"id":1235754,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-03-04T02:32:20.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":22761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":132252,"source":{"system":"sec-edgar","filing":"0001649094-25-000043","document":"wk-form4_1741055534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000043/wk-form4_1741055534.xml","form_type":"4"}},{"id":1252482,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:14:05.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001230724-25-000003","document":"wk-form4_1740186837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000123072425000003/wk-form4_1740186837.xml","form_type":"4"}},{"id":1259877,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-19T23:04:00.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is fully vested and exercisable"}],"balance_after":246827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-25-000014","document":"wk-form4_1740006233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000014/wk-form4_1740006233.xml","form_type":"4"}},{"id":1259876,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-02-19T23:04:00.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":1818,"price":84.58,"value":153766.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $84.125 to $84.985. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":109491,"source":{"system":"sec-edgar","filing":"0001649094-25-000014","document":"wk-form4_1740006233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000014/wk-form4_1740006233.xml","form_type":"4"}},{"id":1259875,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-02-19T23:04:00.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":6182,"price":83.639,"value":517056.298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $83.17 to $84.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":111309,"source":{"system":"sec-edgar","filing":"0001649094-25-000014","document":"wk-form4_1740006233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000014/wk-form4_1740006233.xml","form_type":"4"}},{"id":1259874,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-02-19T23:04:00.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":117491,"source":{"system":"sec-edgar","filing":"0001649094-25-000014","document":"wk-form4_1740006233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000014/wk-form4_1740006233.xml","form_type":"4"}},{"id":1297542,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-22T23:18:51.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":254827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-25-000008","document":"wk-form4_1737587924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000008/wk-form4_1737587924.xml","form_type":"4"}},{"id":1297541,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-01-22T23:18:51.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":683,"price":87.7,"value":59899.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $87.58 to $87.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":109491,"source":{"system":"sec-edgar","filing":"0001649094-25-000008","document":"wk-form4_1737587924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000008/wk-form4_1737587924.xml","form_type":"4"}},{"id":1297540,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-01-22T23:18:51.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":1999,"price":87.247,"value":174406.753,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $86.58 to $87.545. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":110174,"source":{"system":"sec-edgar","filing":"0001649094-25-000008","document":"wk-form4_1737587924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000008/wk-form4_1737587924.xml","form_type":"4"}},{"id":1297539,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-01-22T23:18:51.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":5318,"price":86.084,"value":457794.712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $85.54 to $86.455. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":112173,"source":{"system":"sec-edgar","filing":"0001649094-25-000008","document":"wk-form4_1737587924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000008/wk-form4_1737587924.xml","form_type":"4"}},{"id":1297538,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2025-01-22T23:18:51.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":117491,"source":{"system":"sec-edgar","filing":"0001649094-25-000008","document":"wk-form4_1737587924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000008/wk-form4_1737587924.xml","form_type":"4"}},{"id":1325362,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":262827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1325361,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"sale","planned":true,"acquired":false,"shares":280,"price":90.241,"value":25267.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $90.095 to $90.41. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":109491,"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1325360,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"sale","planned":true,"acquired":false,"shares":3157,"price":89.312,"value":281957.984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $88.98 to $89.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":109771,"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1325359,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"sale","planned":true,"acquired":false,"shares":3373,"price":88.701,"value":299188.473,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $87.895 to $88.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":112928,"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1325358,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"sale","planned":true,"acquired":false,"shares":1190,"price":87.256,"value":103834.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $86.84 to $87.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":116301,"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1325357,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-12-19T21:07:14.000Z","date":"2024-12-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":117491,"source":{"system":"sec-edgar","filing":"0001649094-24-000126","document":"wk-form4_1734642427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/wk-form4_1734642427.xml","form_type":"4"}},{"id":1359093,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-19T21:43:05.000Z","date":"2024-11-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":270827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000112","document":"wk-form4_1732052574.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000112/wk-form4_1732052574.xml","form_type":"4"}},{"id":1359092,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-11-19T21:43:05.000Z","date":"2024-11-18","kind":"sale","planned":true,"acquired":false,"shares":132,"price":87.05,"value":11490.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."}],"balance_after":109491,"source":{"system":"sec-edgar","filing":"0001649094-24-000112","document":"wk-form4_1732052574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000112/wk-form4_1732052574.xml","form_type":"4"}},{"id":1359091,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-11-19T21:43:05.000Z","date":"2024-11-18","kind":"sale","planned":true,"acquired":false,"shares":1757,"price":86.486,"value":151955.902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $85.97 to $86.865. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":109623,"source":{"system":"sec-edgar","filing":"0001649094-24-000112","document":"wk-form4_1732052574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000112/wk-form4_1732052574.xml","form_type":"4"}},{"id":1359090,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-11-19T21:43:05.000Z","date":"2024-11-18","kind":"sale","planned":true,"acquired":false,"shares":6111,"price":85.595,"value":523071.045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $84.97 to $85.965. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":111380,"source":{"system":"sec-edgar","filing":"0001649094-24-000112","document":"wk-form4_1732052574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000112/wk-form4_1732052574.xml","form_type":"4"}},{"id":1359089,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-11-19T21:43:05.000Z","date":"2024-11-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":117491,"source":{"system":"sec-edgar","filing":"0001649094-24-000112","document":"wk-form4_1732052574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000112/wk-form4_1732052574.xml","form_type":"4"}},{"id":1371363,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Performance Restricted Stock Units","published_at":"2024-11-09T01:47:06.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":35661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units (\"PSUs\"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return (\"TSR\") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's  continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares."}],"balance_after":35661,"derivative":{"exercise_price":0,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":35661},"source":{"system":"sec-edgar","filing":"0001649094-24-000106","document":"wk-form4_1731116819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000106/wk-form4_1731116819.xml","form_type":"4"}},{"id":1371362,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-11-09T01:47:06.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":87481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the \"Grant Date\"), the Reporting Person was granted a performance stock option to purchase 87,481\nshares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth\nand fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price))."}],"balance_after":87481,"derivative":{"exercise_price":102.7,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":87481},"source":{"system":"sec-edgar","filing":"0001649094-24-000106","document":"wk-form4_1731116819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000106/wk-form4_1731116819.xml","form_type":"4"}},{"id":1380624,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-28T21:11:52.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":false,"shares":19108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":125892,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":19108},"source":{"system":"sec-edgar","filing":"0001649094-24-000084","document":"wk-form4_1730149905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000084/wk-form4_1730149905.xml","form_type":"4"}},{"id":1380623,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-28T21:11:52.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":true,"shares":19108,"price":20.93,"value":399930.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024."}],"balance_after":109491,"source":{"system":"sec-edgar","filing":"0001649094-24-000084","document":"wk-form4_1730149905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000084/wk-form4_1730149905.xml","form_type":"4"}},{"id":1382925,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":278827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382924,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":292827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382923,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":304827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382922,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":312827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382921,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":5886,"price":116.191,"value":683900.226,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $115.88 to $116.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":90383,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382920,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":36114,"price":115.263,"value":4162607.982,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted May 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.825 to $115.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96269,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382919,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":14000,"price":5.35,"value":74900.0,"ownership":{"direct":true},"balance_after":132383,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382918,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":5.35,"value":64200.0,"ownership":{"direct":true},"balance_after":118383,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382917,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":106383,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1382916,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-10-22T20:11:55.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":98383,"source":{"system":"sec-edgar","filing":"0001649094-24-000082","document":"wk-form4_1729627909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/wk-form4_1729627909.xml","form_type":"4"}},{"id":1402385,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-19T21:48:24.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":320827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000071","document":"wk-form4_1726782498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/wk-form4_1726782498.xml","form_type":"4"}},{"id":1402384,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-09-19T21:48:24.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":829,"price":117.5311,"value":97433.2819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $117.11 to $117.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":90383,"source":{"system":"sec-edgar","filing":"0001649094-24-000071","document":"wk-form4_1726782498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/wk-form4_1726782498.xml","form_type":"4"}},{"id":1402383,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-09-19T21:48:24.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":1686,"price":116.29,"value":196064.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $116.06 to $116.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":91212,"source":{"system":"sec-edgar","filing":"0001649094-24-000071","document":"wk-form4_1726782498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/wk-form4_1726782498.xml","form_type":"4"}},{"id":1402382,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-09-19T21:48:24.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":5485,"price":115.5975,"value":634052.2875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $115.06 to $115.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":92898,"source":{"system":"sec-edgar","filing":"0001649094-24-000071","document":"wk-form4_1726782498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/wk-form4_1726782498.xml","form_type":"4"}},{"id":1402381,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-09-19T21:48:24.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":98383,"source":{"system":"sec-edgar","filing":"0001649094-24-000071","document":"wk-form4_1726782498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/wk-form4_1726782498.xml","form_type":"4"}},{"id":1413915,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-09-05T21:18:44.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6337,"price":110.15,"value":698020.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person."}],"balance_after":90383,"source":{"system":"sec-edgar","filing":"0001649094-24-000065","document":"wk-form4_1725571117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000065/wk-form4_1725571117.xml","form_type":"4"}},{"id":1427612,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-20T20:49:55.000Z","date":"2024-08-19","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":328827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000054","document":"wk-form4_1724186989.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000054/wk-form4_1724186989.xml","form_type":"4"}},{"id":1427611,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-08-20T20:49:55.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":3006,"price":79.135,"value":237879.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $78.88 to $79.66. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96720,"source":{"system":"sec-edgar","filing":"0001649094-24-000054","document":"wk-form4_1724186989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000054/wk-form4_1724186989.xml","form_type":"4"}},{"id":1427610,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-08-20T20:49:55.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":4994,"price":78.248,"value":390770.512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $77.875 to $78.78. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":99726,"source":{"system":"sec-edgar","filing":"0001649094-24-000054","document":"wk-form4_1724186989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000054/wk-form4_1724186989.xml","form_type":"4"}},{"id":1427609,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-08-20T20:49:55.000Z","date":"2024-08-19","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":104720,"source":{"system":"sec-edgar","filing":"0001649094-24-000054","document":"wk-form4_1724186989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000054/wk-form4_1724186989.xml","form_type":"4"}},{"id":1450446,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":336827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1450445,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":926,"price":83.137,"value":76984.862,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $82.69 to $83.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96720,"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1450444,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":1479,"price":82.317,"value":121746.843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $81.68 to $82.655. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":97646,"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1450443,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":81.055,"value":202637.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $80.65 to $81.625. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":99125,"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1450442,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":3095,"price":80.115,"value":247955.925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $79.61 to $80.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":101625,"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1450441,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-07-22T20:03:18.000Z","date":"2024-07-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":104720,"source":{"system":"sec-edgar","filing":"0001649094-24-000038","document":"wk-form4_1721678591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/wk-form4_1721678591.xml","form_type":"4"}},{"id":1473182,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T00:30:51.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":344827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000018","document":"wk-form4_1718929843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000018/wk-form4_1718929843.xml","form_type":"4"}},{"id":1473181,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-06-21T00:30:51.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":348,"price":72.556,"value":25249.488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.48 to $72.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96720,"source":{"system":"sec-edgar","filing":"0001649094-24-000018","document":"wk-form4_1718929843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000018/wk-form4_1718929843.xml","form_type":"4"}},{"id":1473180,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-06-21T00:30:51.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":7652,"price":71.893,"value":550125.236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $71.415 to $72.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":97068,"source":{"system":"sec-edgar","filing":"0001649094-24-000018","document":"wk-form4_1718929843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000018/wk-form4_1718929843.xml","form_type":"4"}},{"id":1473179,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-06-21T00:30:51.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,041 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024."}],"balance_after":104720,"source":{"system":"sec-edgar","filing":"0001649094-24-000018","document":"wk-form4_1718929843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000018/wk-form4_1718929843.xml","form_type":"4"}},{"id":1505458,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-22T21:03:24.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":352827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-014108","document":"form4-05222024_090512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924014108/form4-05222024_090512.xml","form_type":"4"}},{"id":1505457,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-05-22T21:03:24.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":4456,"price":75.46,"value":336249.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $74.95 to $75.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":95679,"source":{"system":"sec-edgar","filing":"0001415889-24-014108","document":"form4-05222024_090512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924014108/form4-05222024_090512.xml","form_type":"4"}},{"id":1505456,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-05-22T21:03:24.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":3544,"price":74.396,"value":263659.424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.95 to $74.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100135,"source":{"system":"sec-edgar","filing":"0001415889-24-014108","document":"form4-05222024_090512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924014108/form4-05222024_090512.xml","form_type":"4"}},{"id":1505455,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-05-22T21:03:24.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":103679,"source":{"system":"sec-edgar","filing":"0001415889-24-014108","document":"form4-05222024_090512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924014108/form4-05222024_090512.xml","form_type":"4"}},{"id":1537572,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-22T20:42:15.000Z","date":"2024-04-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":360827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-011322","document":"form4-04222024_080406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/form4-04222024_080406.xml","form_type":"4"}},{"id":1537571,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-04-22T20:42:15.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":376,"price":61.902,"value":23275.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.85 to $62.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":95679,"source":{"system":"sec-edgar","filing":"0001415889-24-011322","document":"form4-04222024_080406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/form4-04222024_080406.xml","form_type":"4"}},{"id":1537570,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-04-22T20:42:15.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":7624,"price":61.244,"value":466924.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.83 to $61.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96055,"source":{"system":"sec-edgar","filing":"0001415889-24-011322","document":"form4-04222024_080406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/form4-04222024_080406.xml","form_type":"4"}},{"id":1537569,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-04-22T20:42:15.000Z","date":"2024-04-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":103679,"source":{"system":"sec-edgar","filing":"0001415889-24-011322","document":"form4-04222024_080406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/form4-04222024_080406.xml","form_type":"4"}},{"id":1565943,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-20T20:29:31.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":368827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-008745","document":"form4-03202024_080321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924008745/form4-03202024_080321.xml","form_type":"4"}},{"id":1565942,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-03-20T20:29:31.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":236,"price":69.642,"value":16435.512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $69.625 to $69.66. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":95679,"source":{"system":"sec-edgar","filing":"0001415889-24-008745","document":"form4-03202024_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924008745/form4-03202024_080321.xml","form_type":"4"}},{"id":1565941,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-03-20T20:29:31.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":7764,"price":68.999,"value":535708.236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $68.58 to $69.495. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":95915,"source":{"system":"sec-edgar","filing":"0001415889-24-008745","document":"form4-03202024_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924008745/form4-03202024_080321.xml","form_type":"4"}},{"id":1565940,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2024-03-20T20:29:31.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":5.35,"value":42800.0,"ownership":{"direct":true},"balance_after":103679,"source":{"system":"sec-edgar","filing":"0001415889-24-008745","document":"form4-03202024_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924008745/form4-03202024_080321.xml","form_type":"4"}},{"id":1603062,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T02:20:26.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on March 31, 2024, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":90000,"derivative":{"exercise_price":73.82,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-24-006473","document":"form4-03052024_020320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006473/form4-03052024_020320.xml","form_type":"4"}}],"next_cursor":"2024-03-05T02:20:26.000000Z,1603062"}